Stablecoin Development's

• SDEV's Stock Performance relative to its Competitors

Hoth Therapeutics Inc Share Performance +7.28% This Quarter

Hoth Therapeutics Inc Profile Hoth Therapeutics Inc's business model focuses on the development and commercialization of innovative therapies for dermatological disorders and other related conditions. More about Hoth Therapeutics Inc 's Market Share

Inventiva S a Share Performance -0.43% Over The Past 5 Days

Inventiva S a Profile Inventiva S is a company that operates using a specific business model. More about Inventiva S a 's Market Share

Kala Bio inc Share Performance -11.02% 30 Days

Kala Bio inc Profile Kala Pharmaceuticals Inc operates on a business model that revolves around the development and commercialization of innovative ophthalmic therapeutics to address unmet needs in eye care. Their approach focuses on utilizing their proprietary mucus-penetrating particle (MPP) technology to enhance drug delivery and improve patient outcomes. By leveraging partnerships and collaborations with industry stakeholders, Kala Pharmaceuticals aims to bring novel therapies to market and improve the standard of care for various eye diseases. More about Kala Bio inc 's Market Share

Kiora Pharmaceuticals Inc Share Performance -8.06% One Year

Kiora Pharmaceuticals Inc Profile Kiora Pharmaceuticals Inc operates with a business model focused on the research, development, and commercialization of innovative pharmaceutical products for various medical conditions and diseases. The company aims to create value through the discovery of new drugs, rigorous clinical trials, and strategic partnerships for ultimate patient benefit and sustainable growth. More about Kiora Pharmaceuticals Inc 's Market Share

Liquidia Corporation Share Performance +138.52% One Year

Liquidia Corporation Profile Liquidia Corporation is a biopharmaceutical company that develops and commercializes products using its proprietary PRINT® technology to design and produce precision-engineered medicines. The company focuses on creating therapies for respiratory diseases and other areas of high unmet medical need, leveraging the potential of its unique particle engineering platform. More about Liquidia Corporation's Market Share

Sources: Stablecoin Development Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, August 29, 2026 5:39 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Stablecoin Development Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.